Search research articles
Contact Us
Filters
Showing results (101-110 of 201) with videos related to
Page
of 21
Sort By:
Agents and Actions. Supplements
|
January 1, 1992
Probing the bradykinin receptor: mapping the geometric topography using ethers of hydroxyproline in novel peptides
D J Kyle, J A Martin, R M Burch, et al.
The Journal of Chemical Physics
|
April 16, 2018
Positron scattering from pyridine
D Stevens, T J Babij, J R Machacek, et al.
Plos One
|
November 30, 2022
Rapid carbon accumulation at a saltmarsh restored by managed realignment exceeded carbon emitted in direct site construction
Hannah L Mossman, Nigel Pontee, Katie Born, et al.
The Journal of Chemical Physics
|
July 24, 2014
Low energy positron interactions with uracil--total scattering, positronium formation, and differential elastic scattering cross sections
E K Anderson, R A Boadle, J R Machacek, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
February 12, 2013
Low-energy electron and positron transport in gases and soft-condensed systems of biological relevance
R D White, W Tattersall, G Boyle, et al.
British Journal of Pharmacology
|
August 9, 2006
In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor?
B B Yao, S Mukherjee, Y Fan, et al.
Journal of Medicinal Chemistry
|
August 1, 1991
Probing the bradykinin receptor: mapping the geometric topography using ethers of hydroxyproline in novel peptides
D J Kyle, J A Martin, R M Burch, et al.
Plant, Cell & Environment
|
April 1, 2018
Differences in leaf thermoregulation and water use strategies between three co-occurring Atlantic forest tree species
Sophie Fauset, Helber C Freitas, David R Galbraith, et al.
Alzheimer Disease and Associated Disorders
|
January 1, 1995
Potential treatment of Alzheimer disease using cholinergic channel activators (ChCAs) with cognitive enhancement, anxiolytic-like, and cytoprotective properties
S P Arneric, J P Sullivan, M W Decker, et al.
Proceedings of the Western Pharmacology Society
|
January 1, 1995
Cholinergic channel activators: novel opportunities for the treatment of CNS disorders
J P Sullivan, M W Decker, D Donnelly-Roberts, et al.
Page
of 21
Search research articles
Search
Showing results (101-110 of 201) with videos related to
Sort By:
Page
of 21
Agents and Actions. Supplements
|
January 1, 1992
Probing the bradykinin receptor: mapping the geometric topography using ethers of hydroxyproline in novel peptides
D J Kyle, J A Martin, R M Burch, et al.
The Journal of Chemical Physics
|
April 16, 2018
Positron scattering from pyridine
D Stevens, T J Babij, J R Machacek, et al.
Plos One
|
November 30, 2022
Rapid carbon accumulation at a saltmarsh restored by managed realignment exceeded carbon emitted in direct site construction
Hannah L Mossman, Nigel Pontee, Katie Born, et al.
The Journal of Chemical Physics
|
July 24, 2014
Low energy positron interactions with uracil--total scattering, positronium formation, and differential elastic scattering cross sections
E K Anderson, R A Boadle, J R Machacek, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
February 12, 2013
Low-energy electron and positron transport in gases and soft-condensed systems of biological relevance
R D White, W Tattersall, G Boyle, et al.
British Journal of Pharmacology
|
August 9, 2006
In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor?
B B Yao, S Mukherjee, Y Fan, et al.
Journal of Medicinal Chemistry
|
August 1, 1991
Probing the bradykinin receptor: mapping the geometric topography using ethers of hydroxyproline in novel peptides
D J Kyle, J A Martin, R M Burch, et al.
Plant, Cell & Environment
|
April 1, 2018
Differences in leaf thermoregulation and water use strategies between three co-occurring Atlantic forest tree species
Sophie Fauset, Helber C Freitas, David R Galbraith, et al.
Alzheimer Disease and Associated Disorders
|
January 1, 1995
Potential treatment of Alzheimer disease using cholinergic channel activators (ChCAs) with cognitive enhancement, anxiolytic-like, and cytoprotective properties
S P Arneric, J P Sullivan, M W Decker, et al.
Proceedings of the Western Pharmacology Society
|
January 1, 1995
Cholinergic channel activators: novel opportunities for the treatment of CNS disorders
J P Sullivan, M W Decker, D Donnelly-Roberts, et al.
Page
of 21